{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F202-tau-protein-pathology-in-alzheimers-disease-july-2021-MbVuPVLM","width":444,"version":"1.0","type":"rich","title":"202 - Tau protein pathology in Alzheimer's Disease: July 2021","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/ae0e7644-9da0-461c-a400-229ea3588cfb/slide2-3.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/abf1788a-1ba4-45e0-afb8-9beb7d0a17c7\" height=\"200\" width=\"100%\" title=\"202 - Tau protein pathology in Alzheimer&apos;s Disease: July 2021\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Kate brings you the latest research on tau pathology in Alzheimer's Disease. This includes post-translational modifications, tau aggregation and seeding, and targeting tau in treatment development. Enjoy! \n\nSections in this episode: \nTau Pathology (4:35) \nPost-translational modifications (4:56) \nTau aggregation and seeding behaviour (16:30) \nTargeting Tau for Treatment Development (21:09) "}